These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18572639)

  • 41. Seroprevalence of TORCH infections in antenatal and HIV positive patient populations.
    Singh L; Mishra S; Prasanna S; Cariappa MP
    Med J Armed Forces India; 2015 Apr; 71(2):135-8. PubMed ID: 25859075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing.
    Li Z; Yan C; Liu P; Yan R; Feng Z
    Clin Chim Acta; 2009 May; 403(1-2):212-5. PubMed ID: 19302994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TORCH testing in non-familial paediatric cataract.
    Mc Loone E; Joyce N; Coyle P
    Eye (Lond); 2016 Sep; 30(9):1275-6. PubMed ID: 27494085
    [No Abstract]   [Full Text] [Related]  

  • 44. Congenital and perinatal infections: throwing new light with an old TORCH.
    Shet A
    Indian J Pediatr; 2011 Jan; 78(1):88-95. PubMed ID: 20953849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region.
    Deka S; Kalita D; Paul M; Badoni G; Mathuria YP
    Cureus; 2022 Feb; 14(2):e21946. PubMed ID: 35273887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
    Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
    Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women.
    Rasti S; Ghasemi FS; Abdoli A; Piroozmand A; Mousavi SG; Fakhrie-Kashan Z
    Congenit Anom (Kyoto); 2016 Mar; 56(2):73-8. PubMed ID: 26499091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?
    van der Weiden S; de Jong EP; Te Pas AB; Middeldorp JM; Vossen AC; Rijken M; Walther FJ; Lopriore E
    Early Hum Dev; 2011 Feb; 87(2):103-7. PubMed ID: 21145674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TORCH screening in polyhydramnios: an observational study.
    Fayyaz H; Rafi J
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1069-72. PubMed ID: 21923307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance characteristics of six IMMULITE 2000 TORCH assays.
    Owen WE; Martins TB; Litwin CM; Roberts WL
    Am J Clin Pathol; 2006 Dec; 126(6):900-5. PubMed ID: 17074686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of antibodies against TORCH agents during pregnancy].
    Ustaçelebi S; Köksal I; Cantürk H; Saify SJ; Ersöz D; Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):1-8. PubMed ID: 3014280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
    Garland SM; Gilbert GL
    Med J Aust; 1993 Sep; 159(5):346-8. PubMed ID: 8395645
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevalence of Serum Antibodies to TORCH Infection in and Around Varanasi, Northern India.
    Sen MR; Shukla BN; Tuhina B
    J Clin Diagn Res; 2012 Nov; 6(9):1483-5. PubMed ID: 23285435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TORCH agents in pregnant Saudi women.
    Ghazi HO; Telmesani AM; Mahomed MF
    Med Princ Pract; 2002; 11(4):180-2. PubMed ID: 12424411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Six-sigma and quality planning of TORCH tests in the Peruvian population: a single-center cross-sectional study.
    Moya-Salazar J; SantaMaria BM; Moya-Salazar MM; Rojas-Zumaran V; Chicoma-Flores K; Contreras-Pulache H
    BMC Res Notes; 2022 Jan; 15(1):16. PubMed ID: 35016699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation between TORCH infections and abnormal pregnant outcomes].
    Zhang QQ; Cheng JZ; Wang FH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):209-10. PubMed ID: 23894850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid detection of herpes simplex virus in clinical specimens by use of a capture biotin-streptavidin enzyme-linked immunosorbent assay.
    Nerurkar LS; Namba M; Brashears G; Jacob AJ; Lee YJ; Sever JL
    J Clin Microbiol; 1984 Jul; 20(1):109-14. PubMed ID: 6086705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxoplasma gondii: enzyme-linked immunosorbent assay based on a recombinant multi-epitope peptide for distinguishing recent from past infection in human sera.
    Dai JF; Jiang M; Qu LL; Sun L; Wang YY; Gong LL; Gong RJ; Si J
    Exp Parasitol; 2013 Jan; 133(1):95-100. PubMed ID: 23137661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
    Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
    Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.